###begin article-title 0
###xml 14 20 <span type="species:ncbi:9913">Bovine</span>
Resistance of Bovine Spongiform Encephalopathy (BSE) Prions to Inactivation
###end article-title 0
###begin p 1
Current address: Novartis Vaccines and Diagnostics, Emeryville, California, United States of America
###end p 1
###begin p 2
Conceived and designed the experiments: KG DP SBP. Performed the experiments: KG DVG RB RS SJD. Analyzed the data: KG DVG RB RS SJD SBP. Wrote the paper: KG DVG SJD SBP.
###end p 2
###begin p 3
###xml 808 810 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1140 1141 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 318 324 <span type="species:ncbi:9913">cattle</span>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
###xml 531 536 <span type="species:ncbi:10090">mouse</span>
###xml 924 929 <span type="species:ncbi:10090">mouse</span>
###xml 983 989 <span type="species:ncbi:9913">cattle</span>
###xml 1033 1038 <span type="species:ncbi:9606">human</span>
Distinct prion strains often exhibit different incubation periods and patterns of neuropathological lesions. Strain characteristics are generally retained upon intraspecies transmission, but may change on transmission to another species. We investigated the inactivation of two related prions strains: BSE prions from cattle and mouse-passaged BSE prions, termed 301V. Inactivation was manipulated by exposure to sodium dodecyl sulfate (SDS), variations in pH, and different temperatures. Infectivity was measured using transgenic mouse lines that are highly susceptible to either BSE or 301V prions. Bioassays demonstrated that BSE prions are up to 1,000-fold more resistant to inactivation than 301V prions while Western immunoblotting showed that short acidic SDS treatments reduced protease-resistant PrPSc from BSE prions and 301V prions at similar rates. Our findings argue that despite being derived from BSE prions, mouse 301V prions are not necessarily a reliable model for cattle BSE prions. Extending these comparisons to human sporadic Creutzfeldt-Jakob disease and hamster Sc237 prions, we found that BSE prions were 10- and 106-fold more resistant to inactivation, respectively. Our studies contend that any prion inactivation procedures must be validated by bioassay against the prion strain for which they are intended to be used.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 5 8 <span type="species:ncbi:9913">cow</span>
###xml 37 43 <span type="species:ncbi:9913">bovine</span>
###xml 119 125 <span type="species:ncbi:9606">humans</span>
###xml 533 539 <span type="species:ncbi:9606">humans</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 610 615 <span type="species:ncbi:10090">mouse</span>
###xml 1014 1019 <span type="species:ncbi:10090">mouse</span>
"Mad cow" disease, formally known as bovine spongiform encephalopathy (BSE), belongs to a family of diseases affecting humans and a number of commercially important animal species. These diseases are not spread by bacteria or viruses, but by infectious proteins, termed "prions." Prions are known to be very difficult to inactivate, but little is known about the relative difficulty of inactivation for prions from different species. Here, we studied the inactivation of BSE prions and compared it to the inactivation of prions from humans, mice, and hamsters. We used highly sensitive, genetically engineered mouse models to detect low levels of infectivity. We then quantified the levels of inactivation for a range of treatments and calculated differences between prions from different species. We found that naturally occurring BSE prions can be up to 1 million times more difficult to inactivate than the most commonly used hamster prions. BSE prions were also 1,000 times more difficult to inactivate than a mouse prion that was thought to be a surrogate for BSE prions. This study demonstrates that prion inactivation procedures need to be validated directly against the prion strains for which they are intended to be used.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 156 162 <span type="species:ncbi:9606">humans</span>
###xml 164 170 <span type="species:ncbi:9913">bovine</span>
###xml 266 271 <span type="species:ncbi:9940">sheep</span>
###xml 276 281 <span type="species:ncbi:9925">goats</span>
Prions are proteinaceous infectious particles that cause invariably fatal neurodegenerative diseases, including Creutzfeldt-Jakob disease (CJD) and kuru in humans, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) in deer and elk, and scrapie in sheep and goats. The only known component of the prion is an alternatively folded isoform, denoted PrPSc, of the prion protein (PrP). The PrPSc isoform is derived from the normal, cellular PrP, denoted PrPC, through a poorly understood process. Accumulation of PrPSc in the central nervous system results in spongiform changes and death.
###end p 7
###begin p 8
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Kimberlin1">[1]</xref>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Asante1">[4]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Bruce1">[5]</xref>
###xml 502 504 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 504 507 504 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz1">[3]</xref>
###xml 509 512 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Bessen1">[6]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Thackray1">[11]</xref>
Distinct prions strains often exhibit different incubation periods and patterns of neuropathological lesions. Strain characteristics are generally retained upon intraspecies transmission, but may change on transmission to another species [1]-[4]. For many years, the biological properties of prion strains were thought to be encoded by a nucleic acid [5] but none was found. Data from numerous studies offer convincing evidence that strain-specified information is enciphered in the conformation of PrPSc[3], [6]-[11].
###end p 8
###begin p 9
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Gordon1">[12]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Alper1">[13]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Alper2">[14]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Prusiner1">[15]</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Millson1">[16]</xref>
###xml 873 877 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Prusiner2">[17]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Prusiner3">[18]</xref>
###xml 151 156 <span type="species:ncbi:9940">sheep</span>
###xml 255 260 <span type="species:ncbi:9940">sheep</span>
###xml 484 498 <span type="species:ncbi:10036">Syrian hamster</span>
Among the characteristics that distinguish prion strains is resistance to inactivation. The extreme resistance of prions was first noted when numerous sheep immunized against looping-ill virus developed scrapie. The inoculum had been prepared from pooled sheep brains, spinal cords, and spleens, treated with formalin and certified free of viruses [12]. Later, the resistance of prions to both ionizing and ultraviolet radiation was found [13],[14]. As preparations of Sc237-infected Syrian hamster brain were progressively enriched for scrapie infectivity, procedures that modified proteins were found to inactivate the samples, while those that modified nucleic acids had no effect [15]. The results of numerous earlier studies concluded that protein denaturants were effective at reducing infectivity titers [16] but that complete inactivation required harsh conditions [17],[18].
###end p 9
###begin p 10
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-World1">[19]</xref>
###xml 782 786 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Brown1">[20]</xref>
###xml 787 791 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Sonntag1">[21]</xref>
###xml 1022 1026 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-World1">[19]</xref>
###xml 1380 1384 1368 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Korth1">[22]</xref>
###xml 1597 1601 1585 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 1259 1263 <span type="species:ncbi:10090">mice</span>
###xml 1286 1291 <span type="species:ncbi:9606">human</span>
###xml 1292 1297 <span type="species:ncbi:10090">mouse</span>
###xml 1333 1338 <span type="species:ncbi:9606">human</span>
###xml 1398 1403 <span type="species:ncbi:9606">human</span>
###xml 1440 1444 <span type="species:ncbi:10090">mice</span>
The BSE epidemic and almost 200 cases of variant CJD in the United Kingdom as well as the growing problem of CWD in the United States have raised concerns about the spread of prion infectivity. These diseases highlight the need to decontaminate effectively meat processing equipment and other instrumentation of prions. Procedures used for routine sterilization of surgical instruments do not inactivate prions, which led to the development of stringent recommendations for reprocessing instruments used on known or suspected CJD cases [19]. These recommendations include autoclaving at 121degreesC in the presence of 1 M sodium hydroxide, or soaking in 2% sodium hypochlorite for 1 h. However, these highly corrosive procedures can cause significant damage to surgical instruments [20],[21] and therefore, are rarely used. Other less stringent procedures, such as autoclaving at 134degreesC for 18 min, are also included in the recommendations although it is acknowledged that these may not completely remove infectivity [19]. Moreover, the recommendations for prion inactivation are based on rodent-passaged prion isolates, because measuring infectivity in more relevant species is extremely expensive and time consuming. The development of transgenic (Tg) mice expressing a chimeric human/mouse PrP that are highly susceptible to human prions provided a sensitive model system [22]. Bioassay of human sporadic (s) CJD prions in these Tg mice demonstrated that sCJD prions are significantly more resistant to inactivation, by sodium dodecyl sulfate (SDS) at acidic pH, than hamster Sc237 prions [23].
###end p 10
###begin p 11
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Fraser1">[24]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Bruce2">[25]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-McLeod1">[26]</xref>
###xml 1033 1035 1033 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Kimberlin3">[27]</xref>
###xml 1313 1317 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Marsh1">[28]</xref>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 506 512 <span type="species:ncbi:9913">cattle</span>
###xml 543 548 <span type="species:ncbi:10090">mouse</span>
###xml 574 580 <span type="species:ncbi:9913">bovine</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 756 761 <span type="species:ncbi:10090">mouse</span>
We report here on the inactivation of BSE prions and a mouse-passaged BSE strain, termed 301V. The initial transmission of BSE prions to wild-type (wt) mice gave rise to multiple strains, one of which (301V) had a shorter incubation period in mice expressing the PrP-B polymorphic isoform [24],[25]. Even though 301V has been passaged in mice, it has been assumed by some authors to be a model for the original BSE strain [26]. Due to the major logistical problems of performing inoculation experiments on cattle, we chose highly sensitive Tg mouse models expressing either bovine (Bo) PrP or mouse (Mo) PrP-B. Inactivation of BSE and 301V prions was accomplished by varying the SDS concentration, the pH and temperature. Infectivity was measured using Tg mouse lines that are highly susceptible to either BSE or 301V prions. Bioassays demonstrated that BSE prions are up to 1,000-fold more resistant to inactivation than 301V prions while Western immunoblotting showed that short acidic SDS treatments reduced protease-resistant PrPSc from BSE prions and 301V prions at similar rates. We also found that BSE prions are 10- and 1,000,000-fold more resistant to inactivation than sCJD or hamster Sc237 prions, respectively. The hamster Sc237 strain is identical to the 263K strain used by other investigators [27],[28]. Our studies contend that prion inactivation procedures must be validated by bioassays against the prion strain for which they are intended to be used.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
Inocula
###end title 13
###begin p 14
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Carlson1">[29]</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott1">[30]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Buschmann1">[31]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 138 144 <span type="species:ncbi:9913">Cattle</span>
###xml 383 388 <span type="species:ncbi:9606">Human</span>
Mouse 301V, originally a gift from Dr. H. Fraser, was serially passaged in B6.I mice expressing the mouse PrP-B polymorphic isoform [29]. Cattle BSE was from a histopathologically confirmed Hereford bull, case PG31/90, reported previously [30]. This BSE sample showed an electrophoretic banding pattern similar to other BSE samples [31], arguing that it is a "classical" BSE strain. Human sCJD and hamster Sc237 samples were previously described [23].
###end p 14
###begin p 15
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott2">[32]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Safar2">[33]</xref>
Brain homogenates (10% w/v) were prepared in Ca2+ and Mg2+-free phosphate buffered saline (PBS; Invitrogen, Carlsbad, CA), by either repeated extrusion through successively smaller needles, via tissue disruption using stainless steel beads in a Mini-BeadBeater-8 apparatus (BioSPec, Bartlesville, OK), or with a PowerGen 125 homogenizer, as previously described [23],[32],[33].
###end p 15
###begin p 16
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
Four-millimeter segments of stainless steel suture wire (Ethicon, Cornelia, GA) were incubated in brain homogenate as previously described [23].
###end p 16
###begin title 17
Prion inactivation treatments
###end title 17
###begin p 18
###xml 284 286 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Acidic SDS treatments were performed by incubating 50-microl aliquots of brain homogenate with 2x concentration of acidic SDS, for various durations (30 seconds to 18 h) and temperatures (65, 121, or 134degreesC). Samples were then neutralized to stop the inactivation, and either PrPSc levels were detected by Western blotting or samples were prepared for infectivity bioassay.
###end p 18
###begin title 19
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
PrPSc detection by immunoblotting
###end title 19
###begin p 20
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Supattapone1">[34]</xref>
Treated samples were neutralized and PrPSc was determined by limited proteinase K (PK) digestion and immunoblotting as described previously [34]. After incubations, 890 microl of cold neutralization buffer [4% Sarkosyl; 100 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES; pH 7.5); 200 mM NaCl] was added to each sample. Protease digestion was performed with 20 microg of PK/ml (Invitrogen, Carlsbad, CA) for 1 h at 37degreesC. Digestions were terminated by the addition of 10 microl of 0.1 M phenylmethylsulfonyl fluoride in absolute ethanol (Roche, Indianapolis, IN). Digested samples were then resuspended in a final volume of 200 microl using neutralization buffer mixed with 4x LDS sample buffer (Invitrogen) and 10x reducing agent (Invitrogen). Samples were boiled for 10 min at 100degreesC prior to electrophoresis on NuPAGE Bis-Tris 4-12% gels (Invitrogen). Proteins were transferred onto a PVDF membrane using the iBlot dry blotting system (Invitrogen).
###end p 20
###begin p 21
Material was eluted from wires by incubating in 10% SDS, 20 mM dithiothreitol (DTT) at 100degreesC for 5 min. The resulting solution was loaded onto a Minifold slot blot apparatus (Schleicher & Schuell, Florham Park, NJ) containing a PVDF membrane presoaked in ethanol.
###end p 21
###begin p 22
Membranes were blocked for 30 min with 5% nonfat milk in TBST (100 mM Tris-HCl, pH 8.0; 150 mM NaCl; 0.5% Tween-20) and incubated with HRP-conjugated HuM-P monoclonal antibody diluted to 0.05 microg/ml in TBST for 1 h at room temperature. Following three 10-min washes in TBST with water rinses, membranes were developed using an enhanced chemiluminescent (ECL) detection system (Amersham, Piscataway, NJ), followed by exposure to X-ray film. Densitometry was performed with ImageJ Software (NIH, Bethesda, MD).
###end p 22
###begin title 23
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
Bioassay in transgenic mice
###end title 23
###begin p 24
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Safar3">[35]</xref>
###xml 316 318 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 434 438 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 438 441 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 475 479 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott3">[36]</xref>
###xml 641 645 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott3">[36]</xref>
###xml 743 747 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 747 750 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 103 109 <span type="species:ncbi:9913">bovine</span>
###xml 250 265 <span type="species:ncbi:10090">transgenic mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
To directly measure infectivity of BSE prions, we performed bioassays in homozygous Tg mice expressing bovine PrP, Tg(BoPrP+/+)4092/Prnp0/0, described previously [35]. In order to develop a sensitive and rapid model for the detection of 301V prions, transgenic mice expressing MoPrP-B at approximately4-fold that of wt mice were generated. The open reading frame of MoPrP-B was cloned into the Cos.tet vector, then microinjected into Prnp0/0 zygotes, as previously described [36]. Potential founder mice were identified by dot blot of genomic DNA and binding of a radiolabeled probe complementary to the 3' untranslated region of the vector [36]. From a founder with a high copy number, we developed a hemizygous line, denoted Tg(MoPrP-B)2091/Prnp0/0 mice.
###end p 24
###begin p 25
###xml 401 405 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 405 408 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 561 565 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 646 650 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Carlson1">[29]</xref>
###xml 651 655 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott2">[32]</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">Mice</span>
All mice were inoculated intracerebrally with a 30-microl aliquot of sample. Samples treated with acidic SDS were neutralized by addition of an equal volume of neutralization buffer, then diluted 10-fold in 5% BSA in PBS, to minimize nonspecific binding to the vial. For serial dilution of brain homogenate, three independent replicates of 10 ten-fold serial dilutions of 301V prions were prepared in Prnp0/0 brain homogenate, and each inoculated into groups of four mice. Stainless-steel wires coated in brain homogenate were implanted as previously described [23]. Mice were monitored for onset of clinical signs of prion disease, as described [29],[32].
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Giles1">[37]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Kaplan1">[38]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Brookmeyer1">[39]</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Cox1">[40]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Cox2">[41]</xref>
###xml 1244 1248 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Holt1">[42]</xref>
While incubation periods are commonly reported as the mean time from inoculation to onset of disease, analysis of this duration for samples harboring low infectivity titers requires more rigorous analysis [23],[37]. For the studies reported here, a range of survival analysis techniques was employed to enable censored data to be included in the calculations. Median incubation periods were calculated using the Kaplan-Meier function [38], and 95% confidence intervals (ci) were determined [39]. When an upper 95% ci could not be calculated by survival analysis techniques, it was estimated by binomial interpolation, using the times to disease onset of sick animals. To determine how hazard (disease onset) varied with time, we developed both semi-parametric Cox [40] and fully parametric Weibull [41] regression models from survival data for serially diluted brain homogenate. We also studied how hazard varied by dilution, as a subjective check of the model, using a seven-parameter spline. To determine log reduction, the survival data for positive control and treated samples were compared to the regression models. When comparing the effect of a given treatment for two strains, individual Cox regression models were stratified by strain [42]. Such survival analysis tools have the advantage of calculating a measure of variability (expressed as 95% ci) for the comparisons.
###end p 27
###begin p 28
###xml 94 96 89 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">jk</sub>
###xml 108 109 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sub>
###xml 121 122 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sub>
###xml 141 143 124 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">jk</sub>
###xml 257 258 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 258 260 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">jk</sub>
###xml 269 271 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">jk</sub>
###xml 276 277 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sub>
###xml 535 537 511 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j0</sub>
###xml 540 542 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j1</sub>
Specifically, to determine log reduction, we used terms for log dilution and treatment: lambdajk(t) = lambdak(t) exp(betak log dilution+deltajk treatment), where the subscripts k and j denote strain and treatment, respectively. The equivalent log reduction djk = -deltajk/betak for the j treatment was then determined separately for each strain. The equivalent log reduction for a treatment is then the dilution for which the Cox model predicts the hazard of illness equals the hazard in the treated animals. We determined 95% ci for dj0, dj1, and their difference using profile likelihood ratio-based confidence intervals. All calculations were performed with Stata 9 (Stata Corp., College Station, TX) and R (R Foundation for Statistical Computing, Vienna, Austria).
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Prion strains have unique electrophoretic characteristics
###end title 30
###begin p 31
###xml 131 133 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 161 178 161 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1A, lane 1</xref>
###xml 244 264 244 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1A, lanes 2&#8211;4</xref>
###xml 455 457 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
Western immunoblotting of the four prion strains in this study revealed distinct electrophoretic profiles. While unglycosylated PrPSc of BSE migrated to 19 kDa (Figure 1A, lane 1), those of 301V, sCJD, and Sc237 had a molecular mass of 21 kDa (Figure 1A, lanes 2-4). While the host species may influence the glycoforms ratios, it is interesting to note that mouse 301V and hamster Sc237 gave similar banding patterns for un-, mono-, and diglycosylated PrPSc.
###end p 31
###begin title 32
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Strain characterization and PrPSc levels before and after acidic SDS treatment, by gel electrophoresis.
###end title 32
###begin p 33
###xml 295 297 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 491 493 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 670 672 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 146 149 <span type="species:ncbi:9913">cow</span>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 340 346 <span type="species:ncbi:9913">cattle</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
###xml 533 539 <span type="species:ncbi:9913">cattle</span>
(A) Western blot of samples after limited digestion with proteinase K. Brain homogenates (0.5 mg equivalent loaded per lane) were prepared from a cow with BSE (lane 1), mouse infected with 301V (lane 2), human with sCJD (lane 3), and hamster infected with Sc237 (lane 4) prions. (B) Residual PrPSc levels of mouse 301V (filled symbols) and cattle BSE (open symbols) after treatment with 4% SDS-1% AcOH at 65degreesC, for 0.5 min, 1 min, 2 min, 4 min, or 8 min, as indicated. (C) Residual PrPSc levels of mouse 301V (filled bars) and cattle BSE (open bars) after treatment with 4% SDS, 1% AcOH, or water for 18 h at 65degreesC, as indicated. For (B) and (C), residual PrPSc levels were quantified by densitometry and compared to untreated controls. Values represent means with error bars representing standard deviations, from at least three independent measurements.
###end p 33
###begin title 34
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 24 30 <span type="species:ncbi:9913">cattle</span>
PrPSc of mouse 301V and cattle BSE show similar resistance to acidic SDS
###end title 34
###begin p 35
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 197 199 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 250 252 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 291 293 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 357 359 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 361 370 355 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1B</xref>
###xml 431 433 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 529 538 523 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1C</xref>
###xml 643 645 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 673 682 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1C</xref>
###xml 38 44 <span type="species:ncbi:9913">cattle</span>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 343 349 <span type="species:ncbi:9913">cattle</span>
We tested the resistances of PrPSc of cattle BSE and mouse 301V to acidic SDS. Treatment with 4% SDS-1% AcOH for 0.5 to 8 min at 65degreesC demonstrated a clear time dependence for reduction of PrPSc levels for both strains. Although the rates of PrPSc reduction were similar, mouse 301V PrPSc was marginally more resistant to acidic SDS than cattle BSE PrPSc (Figure 1B). Longer treatment durations with acidic SDS reduced the PrPSc signals below detectable levels for both strains, as did treatment with 4% SDS alone for 18 h (Figure 1C). In comparison, incubation with either water or 1% AcOH for 18 h at 65degreesC had little effect on PrPSc levels from either strain (Figure 1C).
###end p 35
###begin title 36
Inactivation of prions measured by bioassay
###end title 36
###begin p 37
###xml 376 380 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 769 776 739 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t001">Table 1</xref>
###xml 382 388 <span type="species:ncbi:9913">Cattle</span>
###xml 397 402 <span type="species:ncbi:10090">mouse</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
To determine more accurately the differences in inactivation of prion strains, we turned to bioassays, which are the only direct method of determining infectivity and have a much larger dynamic range than Western blots. We previously found that a two-step treatment protocol, of 4% SDS at 65degreesC followed by SDS at acidic pH, was the most effective at inactivating prions [23]. Cattle BSE and mouse 301V prions were treated with SDS at acidic pH at 65degreesC and 134degreesC for a range of time periods. Additional samples were incubated at 65degreesC in either water, 1% acetic acid, or 4% SDS, for 18 h; or autoclaved at 134degreesC in the absence of acidic SDS. All experiments were performed in triplicate and inoculated into independent groups of eight mice (Table 1).
###end p 37
###begin title 38
Inactivation of prions in brain homogenates.
###end title 38
###begin p 39
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Median incubation period (IP) in days, 95% confidence intervals (ci), and percentage of animals succumbing to prion disease (24 mice per treatment) were calculated by using Kaplan-Meier analysis.
###end p 39
###begin p 40
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
Mouse 301V prions were only partially inactivated by acidic SDS at 65degreesC for 30 min: the median incubation period was significantly extended from 88 d (95% ci: 81, 97) to 305 d, but the majority of the animals still succumbed to disease. Treatment at 65degreesC for 18 h further decreased infectivity titers, evidenced by fewer animals (13%) becoming ill, but failed to inactivate mouse 301V prions beyond the level of detectability. A similar incidence of sick animals (14%) was seen after autoclaving at a temperature of 134degreesC for 15 min in the absence of acidic SDS, but an equivalent treatment with acidic SDS led to complete survival. Interestingly, treatment with SDS alone at 65degreesC for 18 h led to a significant reduction in mouse 301V infectivity.
###end p 40
###begin p 41
###xml 17 23 <span type="species:ncbi:9913">cattle</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 629 634 <span type="species:ncbi:10090">mouse</span>
Similar to 301V, cattle BSE prions were also resistant to inactivation. Treatment with acidic SDS at 65degreesC for 30 min produced a significant reduction in infectivity, with over 80% of the mice remaining healthy for the duration of the experiment. Increasing the treatment time increased the level of inactivation: after 18 h at 65degreesC with acidic SDS, no mice succumbed to disease. Autoclaving at 134degreesC alone (in the absence of acidic SDS) reduced BSE infectivity, but complete inactivation required 2 h. In the presence of acidic SDS, complete inactivation was achieved in 15 min at 134degreesC, as observed with mouse 301V.
###end p 41
###begin title 42
Developing a standard by serial dilution
###end title 42
###begin p 43
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 542 544 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 692 694 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 779 781 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 788 791 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 845 847 845 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 977 985 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g002">Figure 2</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 356 361 <span type="species:ncbi:10090">mouse</span>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
Due to the different levels of sensitivity of wt and Tg mice to different prion strains, direct comparison of survival is not an accurate method. Rather, the log reduction in infectivity for each strain must be calculated by comparison to serially diluted samples of the same strain. Tg2091 mice were inoculated with three sets of independent dilutions of mouse 301V prions; no statistically significant difference was found between the sets, so the data were combined for further analyses. As the samples of 301V prions were titrated from 10-1 to 10-6 dilution of 10% brain homogenate, the median incubation periods increased from 82 d (95% ci: 69, 90) to 172 d (95% ci: 151, 207). At the 10-7 dilution, only a portion (<25%) of the animals succumbed to disease. For both the 10-8 and 10-10 dilutions, no animals became ill. However, for the 10-9 dilution, one mouse showed clinical signs at 159 d after inoculation, and prion disease was confirmed by Western immunoblotting (Figure 2).
###end p 43
###begin title 44
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Kaplan-Meier survival curves for serially diluted 301V prions bioassayed in Tg(MoPrP-B)2091/Prnp0/0 mice.
###end title 44
###begin p 45
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">Mice</span>
Three independent 10% brain homogenates were serially diluted 10-fold and each inoculated into 4 mice, which were then monitored for clinical symptoms of prion disease. No significant differences were observed among the three dilution series and the data were therefore combined. Incubation period is the number of days from inoculation to manifestation of clinical symptoms. Mice with intercurrent illnesses were censored at the time of euthanasia.
###end p 45
###begin p 46
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Safar3">[35]</xref>
###xml 156 165 156 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000206.s001">Figure S1</xref>
###xml 43 49 <span type="species:ncbi:9913">cattle</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
The incubation periods of serially diluted cattle BSE, human sCJD and hamster Sc237 prions [23],[35] were also analyzed using survival-analysis techniques (Figure S1).
###end p 46
###begin title 47
Fitting a mathematical model of the serial dilution data
###end title 47
###begin p 48
###xml 550 558 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g003">Figure 3</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Therneau1">[43]</xref>
###xml 1161 1170 1161 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000206.s002">Figure S2</xref>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Two statistical methods were used to model the serially diluted mouse 301V prions: (i) a semi-parametric Cox model, which considers relative rate of disease onset, and (ii) the fully parametric Weibull model, which makes more detailed parametric assumptions of how rate of disease varies over time. For each inactivation treatment, log reductions were calculated by both methods. A plot of the log reductions determined using the Weibull model against those calculated by the Cox model demonstrates that the two methods produce very similar results (Figure 3), with a correlation coefficient of 0.99 to the line of identity. We therefore concluded that the additional assumptions of the Weibull model did not lead to greater accuracy, and used the Cox model for subsequent calculations. To test the assumption that the rate of developing disease was linear over time, we examined how hazard rate varied across dilutions, using penalized regression splines [43]. The multi-parameter spline interpolation fitted very closely a two-parameter linear relationship; thus, we found no evidence of non-linearity in the observable range, validating our choice of model (Figure S2).
###end p 48
###begin title 49
Comparison of mathematical models derived from serial dilution data.
###end title 49
###begin p 50
###xml 354 355 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Calculations of log reduction upon inactivation treatment, using the Weibull (abscissa) and Cox (ordinate) models, produce similar results. Serial dilutions of 301V-infected brain homogenate were modeled using the Cox and Weibull regression methods and log reduction was calculated for each treatment by both methods. Samples were treated as follows: ddH2O, 65degreesC, 18 h (a); 1% AcOH, 65degreesC, 18 h (b); 4% SDS, 65degreesC, 18 h (c); 4% SDS-1% AcOH at 65degreesC for 30 min (d), 2 h (e), and 18 h (f); autoclaved at 134degreesC for 15 min (g). The correlation coefficient to the line of identity is 0.99.
###end p 50
###begin title 51
Quantification of prion inactivation
###end title 51
###begin p 52
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t002">Table 2</xref>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
###xml 504 510 <span type="species:ncbi:9913">cattle</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
Values of log reduction in infectivity were calculated for each treatment and strain by comparing survival after treatment with a positive control, using the appropriate Cox model (Table 2). The limit of detectability for each set of experiments is a feature of the infectivity of the positive control and the sensitivity of the transgenic line. In the inactivation experiments based on 4% SDS, the maximum log reduction detectable for each of the four strains was 8.1, 4.0, 7.2, and 7.2 for mouse 301V, cattle BSE, human sCJD, and hamster Sc237, respectively. When all mice survive following inoculation with a sample subjected to an inactivation treatment, the application of survival-analysis techniques enabled the calculation of a lower confidence interval for the level of inactivation.
###end p 52
###begin title 53
Quantification of log reduction in infectivity, with 95% confidence intervals for various prion strains.
###end title 53
###begin title 54
Comparing inactivation between strains
###end title 54
###begin p 55
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 565 566 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 807 808 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 843 844 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 982 983 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 424 429 <span type="species:ncbi:10090">mouse</span>
###xml 446 452 <span type="species:ncbi:9913">cattle</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
###xml 682 688 <span type="species:ncbi:9913">cattle</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1187 1192 <span type="species:ncbi:10090">mouse</span>
###xml 1262 1268 <span type="species:ncbi:9913">cattle</span>
The log difference between strains for a given treatment is simply the arithmetic difference between log reductions, for a given treatment, for the two strains. However, to determine levels of significance and confidence intervals for these differences, the comparisons were stratified using individual Cox models for each strain. For treatments that led to low levels of prion inactivation (H2O or AcOH, 18 h, 65degreesC), mouse 301V prions and cattle BSE prions had only slightly different inactivation profiles, with a log difference of -0.4 (95% ci: -1.0, 0.2; p = 0.1). At higher levels of inactivation, mouse 301V prions were significantly less resistant to inactivation than cattle BSE prions. Treatment with acidic SDS at 65degreesC for 30 min or 2 h, gave log differences of 1.9 (95% ci: 1.0, 2.8; p<0.001) and 2.2 (95% ci: 0.3, 3.6; p = 0.03) respectively; autoclaving at 134degreesC for 15 min in the absence of acidic SDS gave a log difference of 3.3 (95% ci: 2.0, 4.9; p<0.001). For all other inactivation treatments one or both the strains had complete survival of mice and therefore log reduction for the treatments cannot be calculated. At higher levels of inactivation, mouse 301V prions are 100 to 1000-fold less resistant to inactivation than cattle BSE prions.
###end p 55
###begin p 56
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 561 569 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000206.s003">Table S1</xref>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1178 1179 1148 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1196 1197 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
###xml 621 627 <span type="species:ncbi:9913">cattle</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 898 904 <span type="species:ncbi:9913">cattle</span>
###xml 974 980 <span type="species:ncbi:9913">cattle</span>
###xml 1700 1706 <span type="species:ncbi:9913">cattle</span>
Similar treatments on sCJD prions showed them to be approximately 10-fold easier to inactivate than BSE prions, however many treatments led to inactivation beyond the limit of detectability for sCJD prions. With Sc237 prions the 4% SDS treatments were even more effective at resulting in complete survival of bioassay mice, and thus an inability to quantify differences between the strains. We therefore repeated the less effective 2% SDS-1% AcOH procedures on BSE prions and compared them with equivalent inactivation treatments on Sc237 and sCJD prions [23] (Table S1). For human sCJD, values for the log difference to cattle BSE range from non-significant to a log difference of 2.0 (95% ci: 0.7, 3.9; p<0.001) for acidic 4% SDS at 65degreesC for 30 min. In general there was about a 1 log difference, implying that human sCJD prions are approximately10-fold less resistant to inactivation that cattle BSE prions. For Sc237 prions, highly significant differences against cattle BSE prions were found for inactivation treatments with acidic 2% SDS at 65degreesC for 30 min and autoclaving at 121degreesC for 15 min in the absence of acidic SDS, giving log differences of 4.0 (p<0.001) and 5.1 (p<0.001) respectively. In both cases the upper 95% ci cannot be calculated due to the limit of the level of detectability. In nearly all other treatments hamster Sc237 prions were inactivated beyond the level of detectability, i.e. greater than 8.4 log reduction, even when BSE infectivity was only reduced by approximately 2 logs, suggesting a difference of approximately 6 logs. Hamster Sc237 prions were at least 10,000-fold and in some cases up to 1,000,000-fold, less resistant to inactivation than cattle BSE prions.
###end p 56
###begin title 57
Inactivation of prions bound to stainless steel
###end title 57
###begin p 58
###xml 313 320 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t003">Table 3</xref>
###xml 68 74 <span type="species:ncbi:9913">cattle</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
Stainless-steel wires soaked in brain homogenates containing either cattle BSE or mouse 301V prions were subjected to a similar series of inactivation procedures as the brain homogenates. Wires were implanted into the brains of the respective Tg mouse lines, which were then monitored for onset of prion disease (Table 3). To determine the amount of PrP bound to the wires, 20 additional prion-soaked wires were prepared in the same manner, including the repeated washing steps, then boiled with 10% SDS and 20 mM DTT to elute the bound material. PrP was detected by slot blot and compared to a serially diluted, prion-infected brain homogenate. We determined that the amount of PrP bound to each wire was equivalent to that in approximately250 ng of brain tissue. It is not possible to confirm that all protein was eluted from the wires, so this must be taken as a minimum value.
###end p 58
###begin title 59
Inactivation of prions bound to stainless steel.
###end title 59
###begin p 60
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Median incubation period (IP) in days, 95% confidence intervals (ci), and percentage of animals succumbing to prion disease (24 mice per treatment) were calculated by using Kaplan-Meier analysis.
###end p 60
###begin p 61
###xml 275 282 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t003">Table 3</xref>
###xml 459 466 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t001">Table 1</xref>
###xml 628 635 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t003">Table 3</xref>
###xml 637 645 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000206.s004">Table S2</xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 609 615 <span type="species:ncbi:9913">cattle</span>
Inactivation treatments on prion-coated wires produced only moderate reductions in the level of infectivity. For example, autoclaving 301V-coated wires at 134degreesC for 15 min extended the median incubation period from 113 d to 161 d, and 96% of animals developed disease (Table 3). In comparison, the same procedure on 301V-infected brain homogenate extended the median incubation period from 88 d to over 600 d, and only 14% of mice succumbed to disease (Table 1). To remove all detectable infectivity from wires, acidic SDS treatment at elevated temperatures was required. Similar results were found for cattle BSE prions (Table 3, Table S2).
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
The application of survival analysis techniques to prion incubation periods provides a more accurate representation of the data. The distribution of animals succumbing to disease is rarely symmetrical, and not all animals become sick at low levels of infectivity. These factors are reflected by reporting median incubation periods and asymmetric 95% ci, which are by definition wider than standard deviation or standard error of the mean. These techniques also allow us to quantify inactivation using different Tg model systems, in an unbiased way.
###end p 63
###begin p 64
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Ernst1">[44]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Fichet1">[45]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Jackson1">[46]</xref>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
We previously demonstrated that human CJD prions were significantly more resistant to inactivation than hamster Sc237 prions [23]. This differential inactivation of prion strains has also been observed by others. The phenolic detergent Environ LpH was shown to inactivate all detectable infectivity of hamster Sc237 prions [44],[45], but only modestly reduced infectivity of mouse RML prions [46].
###end p 64
###begin p 65
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Taguchi1">[47]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Manuelidis1">[48]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Brown2">[49]</xref>
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 437 448 <span type="species:ncbi:10141">guinea pigs</span>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
###xml 607 617 <span type="species:ncbi:10141">guinea pig</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
Rodent-passaged prion strains are widely used in prion research. While these have been invaluable for understanding prion biology, great care must be taken in extrapolating any characteristics of these prions back to the original species and strain from which they were derived. Recommendations for the inactivation of human CJD prions were partly based on experiments on adapted strains of CJD passaged in mice [47], hamsters [48], and guinea pigs [49]. However, since the sequence of PrPSc is encoded by the host in which the prions were last passaged, these "CJD" strains are actually mouse, hamster and guinea pig prions, respectively, which may exhibit different resistances to inactivation compared to the human CJD prions from which they were originally derived.
###end p 65
###begin p 66
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Parchi1">[50]</xref>
###xml 594 602 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Howells1">[51]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Stack1">[52]</xref>
###xml 951 953 951 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1001 1010 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1B</xref>
###xml 1012 1020 1012 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t001">Tables 1</xref>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000206-t002">2</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 922 928 <span type="species:ncbi:9913">cattle</span>
###xml 937 942 <span type="species:ncbi:10090">mouse</span>
Gel electrophoresis can be used to identify the PK-resistant core of PrPSc, which can differ between strains. This technique was used to classify human prion strains based on the size of the unglycosylated, protease-resistant PrPSc fragments: type 1 results from cleavage at residue 82 and has a fragment size of 21 kDa and type 2 results from cleavage at residue 97 and has a fragment size of 19 kDa [50]. Despite the assumption that 301V is representative of the BSE strain from which it was derived, we observed a difference in the sizes of the unglycosylated bands between the two strains (Figure 1), which is consistent with previously published results. A mixture of N-terminal sequences was obtained from the 301V strain, starting with residue 81 [51]. In contrast, BSE was not recognized by an antibody directed against residues 89-104, suggesting the major cleavage point is within this region [52]. Furthermore, cattle BSE and mouse 301V PrPSc have different susceptibilities to acidic SDS (Figure 1B, Tables 1 and 2), suggesting that they are different strains.
###end p 66
###begin p 67
###xml 236 238 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 410 419 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1B</xref>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 940 942 910 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1051 1060 1019 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000206-g001">Figure 1C</xref>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 351 357 <span type="species:ncbi:9913">cattle</span>
###xml 482 488 <span type="species:ncbi:9913">cattle</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
We observed differences in the relative effectiveness of treatments on the two strains, as measured by Western blots and infectivity bioassay. In all cases, increasing the time and temperature of acidic SDS treatments led to reduced PrPSc levels and increased inactivation. For acidic SDS treatments of <8 min, Western blots of treated mouse 301V and cattle BSE prions showed similar levels of residual PrPSc (Figure 1B). In contrast, longer acidic SDS treatments demonstrated that cattle BSE prions were significantly more resistant to inactivation, up to 1,000-fold compared to mouse 301V prions. PrPSc levels of both 301V and BSE were relatively unchanged by exposure to water or 1% AcOH for 18 h at 65degreesC, compared to approximately10-fold reduction in infectivity as detected by bioassay. For both 301V and BSE prions, incubation with 4% SDS alone for 18 h at 65degreesC, or with 4% SDS-1% AcOH for 8 min at 65degreesC, reduced PrPSc to levels approaching the background signal in Western immunoblots, which implies a reduction of >/=2 logs (Figure 1C).
###end p 67
###begin p 68
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 180 182 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 217 221 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-McKinley1">[53]</xref>
###xml 303 305 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 452 454 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 454 458 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Tremblay1">[54]</xref>
###xml 494 496 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 543 546 531 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Safar1">[8]</xref>
###xml 577 581 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Colby1">[55]</xref>
###xml 610 612 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 621 623 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Western blotting is a rapid and convenient way of determining the level of PrPSc, but it is limited by a dynamic range of approximately100-fold. It has long been known that the PrPSc level correlates with infectivity [53], but the precise relationship between the two remains to be determined. While PrPSc was originally defined as resistance to PK, we have since shown that there are both protease-resistant (r) and protease-sensitive (s) forms of PrPSc[54]. Western blotting only detects rPrPSc, while the conformation-dependent immunoassay [8] and the amyloid seeding assay [55] are able to detect both rPrPSc and sPrPSc.
###end p 68
###begin p 69
###xml 50 52 50 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 274 276 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 342 344 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 726 731 <span type="species:ncbi:10090">mouse</span>
###xml 839 845 <span type="species:ncbi:9913">cattle</span>
The apparent discrepancies we observed between PrPSc level and infectivity for 301V and BSE prions may be due to several factors. First, the sPrPSc fraction, and its associated infectivity, may be variable between 301V and BSE. If 301V and BSE have differing amounts of rPrPSc and sPrPSc, and at least some infectivity is associated with sPrPSc, then Western blot results would not necessarily correlate with infectivity. Second, structural differences between the strains may result in different levels of inactivation. Presumably, the quaternary structure would be broken down first when inactivating prions, whereas the tertiary structure would have to be unfolded to diminish higher levels of infectivity. In such a case, mouse 301V prions may have an equally stable quaternary structure but less stable tertiary structure compared to cattle BSE prions.
###end p 69
###begin p 70
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Taylor1">[56]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Lawson1">[57]</xref>
###xml 799 801 799 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Scott4">[58]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Philipp1">[59]</xref>
###xml 0 6 <span type="species:ncbi:9913">Cattle</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:10090">Mouse</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 905 911 <span type="species:ncbi:9913">cattle</span>
###xml 1044 1050 <span type="species:ncbi:9913">bovine</span>
###xml 1079 1084 <span type="species:ncbi:10090">mouse</span>
###xml 1114 1120 <span type="species:ncbi:9913">cattle</span>
Cattle or human prions passaged in rodents give rise to rodent prions. Mouse 301V prions are very resistant to inactivation [56]. Additionally, a human prion strain causing Gerstmann-Straussler-Scheinker disease was passaged in mice; the resulting strain, termed M1000, was reported to be highly resistant to inactivation [57]. However, for both 301V and M1000, the relative susceptibilities to inactivation were not directly compared to their respective parent strains. We demonstrate here that mouse 301V and its parent strain, BSE, have different resistances to inactivation. Therefore, any extrapolation from a rodent-passaged prion strain to the original parent strain must be interpreted cautiously. A more suitable model for BSE prions may be BSE passaged in Tg(BoPrP) mice, which produce PrPSc with the BoPrP sequence as well as with the same electrophoretic mobility and glycosylation pattern as cattle BSE prions [58]. Infected brains from this line were recently shown to be suitable for evaluation of BSE tests [59]. However, these bovine prions are in the milieu of mouse brain homogenate rather than cattle brain homogenate, and it remains to be determined whether this has an effect on the inactivation characteristics.
###end p 70
###begin p 71
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Peretz3">[23]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Zobeley1">[60]</xref>
###xml 718 722 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Lemmer1">[61]</xref>
###xml 930 934 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000206-Weissmann1">[62]</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 106 112 <span type="species:ncbi:9913">cattle</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
As with the results reported previously for hamster Sc237 and human sCJD prions [23], the inactivation of cattle BSE and mouse 301V prions from stainless-steel surfaces is more difficult than inactivating similar levels of infectivity in brain homogenates. Stainless-steel wire as a model for surface contamination [60] provides a useful tool to study prion inactivation from surgical instruments or machinery used in slaughterhouses. After 4-mm wires were incubated in 10% brain homogenate, then washed extensively, we were able to elute PrP equivalent to approximately250 ng of brain tissue from each wire. Other investigators were able to elute substantially higher PrP levels from wires soaked in brain homogenate [61], but their wires were not exhaustively washed, as ours were. Previous studies, using very similar washing strategies, reported the inability to detect eluted PrP or other proteins from stainless-steel wires [62]. However, 2 M NaOH used in those studies may have hydrolyzed many of the proteins, including PrP.
###end p 71
###begin p 72
###xml 120 126 <span type="species:ncbi:9913">Cattle</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 326 331 <span type="species:ncbi:10090">Mouse</span>
In conclusion, we have quantified the relative resistance to inactivation of four prion strains from different species. Cattle BSE prions appear to be the most resistant strain studied. In comparison, human sCJD prions are approximately 10-fold less resistant to inactivation by SDS at neutral or acidic pH, or by heat alone. Mouse 301V prions are 100- to 1,000-fold less resistant, and hamster Sc237 prions are up to 1,000,000-fold less resistant to inactivation. As shown by our findings, prion inactivation based on rodent-passaged prion strains may not be effective against the naturally occurring strains for which they were developed.
###end p 72
###begin title 73
Supporting Information
###end title 73
###begin p 74
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 255 258 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 64 70 <span type="species:ncbi:9913">cattle</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
Kaplan-Meier survival curves of 10-fold serial dilutions of (A) cattle BSE prions bioassayed in Tg(BoPrP+/+)4092/Prnp0/0 mice; (B) human sCJD prions bioassayed in Tg(MHu2M,M165V,E167Q+/+)22372/Prnp0/0 mice; (C) hamster Sc237 prions bioassayed in Tg(SHaPrP+/+)7/Prnp0/0 mice. Three independent serial dilution experiments were performed for each strain; no significant differences were found between the replicates, so the data were combined.
###end p 74
###begin p 75
(0.38 MB TIF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
Variation of hazard rate across serial dilutions for the 301V prion strain. The multi-parameter spline regression (black) is closely approximated by a linear relationship (gray).
###end p 77
###begin p 78
(0.07 MB TIF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Inactivation of prion strains in brain homogenates.
###end p 80
###begin p 81
(0.06 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 16 22 <span type="species:ncbi:9913">cattle</span>
Inactivation of cattle BSE prions bound to stainless steel wires.
###end p 83
###begin p 84
(0.04 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 142 146 <span type="species:ncbi:10090">mice</span>
The authors thank Ms. Hang Nguyen for expert editorial assistance, Dr. Glenn Telling for cloning the transgenic construct for the Tg(MoPrP-B) mice, and Dr. Pierre Lessard and the staff of the Hunter's Point animal facility.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice.
###end article-title 88
###begin article-title 89
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 93 97 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters.
###end article-title 89
###begin article-title 90
A change in the conformation of prions accompanies the emergence of a new prion strain.
###end article-title 90
###begin article-title 91
###xml 86 101 <span type="species:ncbi:10090">transgenic mice</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.
###end article-title 91
###begin article-title 92
Biological evidence that the scrapie agent has an independent genome.
###end article-title 92
###begin article-title 93
###xml 89 93 <span type="species:ncbi:452646|species:ncbi:9666">mink</span>
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.
###end article-title 93
###begin article-title 94
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
###end article-title 94
###begin article-title 95
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Eight prion strains have PrPSc molecules with different conformations.
###end article-title 95
###begin article-title 96
Strain-specified relative conformational stability of the scrapie prion protein.
###end article-title 96
###begin article-title 97
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.
###end article-title 97
###begin article-title 98
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc.
###end article-title 98
###begin article-title 99
Advances in veterinary research.
###end article-title 99
###begin article-title 100
The exceptionally small size of the scrapie agent.
###end article-title 100
###begin article-title 101
Does the agent of scrapie replicate without nucleic acid?
###end article-title 101
###begin article-title 102
Further purification and characterization of scrapie prions.
###end article-title 102
###begin article-title 103
The effect of selected detergents on scrapie infectivity.
###end article-title 103
###begin article-title 104
Thiocyanate and hydroxyl ions inactivate the scrapie agent.
###end article-title 104
###begin article-title 105
Prions: methods for assay, purification and characterization.
###end article-title 105
###begin article-title 106
Effects on instruments of the World Health Organization-recommended protocols for decontamination after possible exposure to transmissible spongiform encephalopathy-contaminated tissue.
###end article-title 106
###begin article-title 107
Effect of prion decontamination protocols on nickel-titanium rotary surfaces.
###end article-title 107
###begin article-title 108
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
###end article-title 108
###begin article-title 109
Inactivation of prions by acidic sodium dodecyl sulfate.
###end article-title 109
###begin article-title 110
###xml 16 22 <span type="species:ncbi:9913">bovine</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Transmission of bovine spongiform encephalopathy and scrapie to mice.
###end article-title 110
###begin article-title 111
###xml 16 22 <span type="species:ncbi:9913">bovine</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier.
###end article-title 111
###begin article-title 112
###xml 32 38 <span type="species:ncbi:9913">bovine</span>
Proteolytic inactivation of the bovine spongiform encephalopathy agent.
###end article-title 112
###begin article-title 113
###xml 40 44 <span type="species:ncbi:452646|species:ncbi:9666">mink</span>
Comparison of scrapie and transmissible mink encephalopathy in hamsters. I. Biochemical studies of brain during development of disease.
###end article-title 113
###begin article-title 114
###xml 40 44 <span type="species:ncbi:452646|species:ncbi:9666">mink</span>
Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis.
###end article-title 114
###begin article-title 115
###xml 111 126 <span type="species:ncbi:10090">transgenic mice</span>
Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice.
###end article-title 115
###begin article-title 116
###xml 69 75 <span type="species:ncbi:9913">bovine</span>
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice.
###end article-title 116
###begin article-title 117
Atypical BSE in Germany-proof of transmissibility and biochemical characterization.
###end article-title 117
###begin article-title 118
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.
###end article-title 118
###begin article-title 119
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Prion clearance in bigenic mice.
###end article-title 119
###begin article-title 120
Elimination of prions by branched polyamines and implications for therapeutics.
###end article-title 120
###begin article-title 121
###xml 25 31 <span type="species:ncbi:9913">bovine</span>
###xml 105 120 <span type="species:ncbi:10090">transgenic mice</span>
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.
###end article-title 121
###begin article-title 122
###xml 56 71 <span type="species:ncbi:10090">transgenic mice</span>
Chimeric prion protein expression in cultured cells and transgenic mice.
###end article-title 122
###begin article-title 123
Disinfection of prions.
###end article-title 123
###begin article-title 124
Nonparametric estimation from incomplete observations.
###end article-title 124
###begin article-title 125
A confidence interval for the median survival time.
###end article-title 125
###begin article-title 126
Regression models and life-tables.
###end article-title 126
###begin article-title 127
Survival analyses in twin studies and matched pair experiments.
###end article-title 127
###begin article-title 128
Comparative analysis of scrapie agent inactivation methods.
###end article-title 128
###begin article-title 129
Novel methods for disinfection of prion-contaminated medical devices.
###end article-title 129
###begin article-title 130
An enzyme-detergent method for effective prion decontamination of surgical steel.
###end article-title 130
###begin article-title 131
Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
###end article-title 131
###begin article-title 132
Decontamination of Creutzfeldt-Jakob disease and other transmissible agents.
###end article-title 132
###begin article-title 133
Chemical disinfection of Creutzfeldt-Jakob disease virus.
###end article-title 133
###begin article-title 134
Genetic influence on the structural variations of the abnormal prion protein.
###end article-title 134
###begin article-title 135
###xml 147 153 <span type="species:ncbi:9913">bovine</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
Transmissible spongiform encephalopathy strain-associated diversity of N-terminal proteinase K cleavage sites of PrP(Sc) from scrapie-infected and bovine spongiform encephalopathy-infected mice.
###end article-title 135
###begin article-title 136
###xml 69 74 <span type="species:ncbi:9940">sheep</span>
###xml 84 89 <span type="species:ncbi:9940">sheep</span>
###xml 135 141 <span type="species:ncbi:9913">bovine</span>
###xml 209 214 <span type="species:ncbi:9940">sheep</span>
Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies.
###end article-title 136
###begin article-title 137
A protease-resistant protein is a structural component of the scrapie prion.
###end article-title 137
###begin article-title 138
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
###end article-title 138
###begin article-title 139
Prion detection by an amyloid seeding assay.
###end article-title 139
###begin article-title 140
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents.
###end article-title 140
###begin article-title 141
###xml 160 165 <span type="species:ncbi:9606">human</span>
Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain.
###end article-title 141
###begin article-title 142
###xml 53 59 <span type="species:ncbi:9913">bovine</span>
###xml 96 102 <span type="species:ncbi:9606">humans</span>
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.
###end article-title 142
###begin article-title 143
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse brains for evaluation and quality control of BSE tests.
###end article-title 143
###begin article-title 144
Infectivity of scrapie prions bound to a stainless steel surface.
###end article-title 144
###begin article-title 145
Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces.
###end article-title 145
###begin article-title 146
Transmission of prions.
###end article-title 146
###begin p 147
The authors have declared that no competing interests exist.
###end p 147
###begin p 148
This work was supported by grants from the National Institutes of Health (R01AI064709, AG02132, AG10770, and AG021601) as well as by a gift from the G. Harold and Leila Y. Mathers Charitable Foundation.
###end p 148

